219 related articles for article (PubMed ID: 38226932)
1. A review on the use of extracellular vesicles for the delivery of drugs and biological therapeutics.
Amina SJ; Azam T; Dagher F; Guo B
Expert Opin Drug Deliv; 2024; 21(1):45-70. PubMed ID: 38226932
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Exosomes-An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics.
Morishita M; Takahashi Y; Nishikawa M; Takakura Y
J Pharm Sci; 2017 Sep; 106(9):2265-2269. PubMed ID: 28283433
[TBL] [Abstract][Full Text] [Related]
3. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
Lin Y; Lu Y; Li X
J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
[TBL] [Abstract][Full Text] [Related]
4. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
[TBL] [Abstract][Full Text] [Related]
5. Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy.
Del Pozo-Acebo L; Hazas MLL; Tomé-Carneiro J; Gil-Cabrerizo P; San-Cristobal R; Busto R; García-Ruiz A; Dávalos A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499350
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
[TBL] [Abstract][Full Text] [Related]
7. Exosomes as New Generation Vehicles for Drug Delivery: Biomedical Applications and Future Perspectives.
Rajput A; Varshney A; Bajaj R; Pokharkar V
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364116
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.
Chen Z; Xiong M; Tian J; Song D; Duan S; Zhang L
J Nanobiotechnology; 2024 Jan; 22(1):18. PubMed ID: 38172932
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of exosome-targeting peptides via engineered glycosylation.
Hung ME; Leonard JN
J Biol Chem; 2015 Mar; 290(13):8166-72. PubMed ID: 25657008
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the development and establishment of exosome-based drug delivery systems.
Wang J; Chen D; Ho EA
J Control Release; 2021 Jan; 329():894-906. PubMed ID: 33058934
[TBL] [Abstract][Full Text] [Related]
11. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
[TBL] [Abstract][Full Text] [Related]
12. Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics.
Kar R; Dhar R; Mukherjee S; Nag S; Gorai S; Mukerjee N; Mukherjee D; Vatsa R; Chandrakanth Jadhav M; Ghosh A; Devi A; Krishnan A; Thorat ND
ACS Biomater Sci Eng; 2023 Feb; 9(2):577-594. PubMed ID: 36621949
[TBL] [Abstract][Full Text] [Related]
13. Current Strategies for Exosome Cargo Loading and Targeting Delivery.
Zeng H; Guo S; Ren X; Wu Z; Liu S; Yao X
Cells; 2023 May; 12(10):. PubMed ID: 37408250
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-guided extracellular vesicle theranostics in oncology.
Tran PH; Xiang D; Nguyen TN; Tran TT; Chen Q; Yin W; Zhang Y; Kong L; Duan A; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Ma Y; Jiang G; Duan W
Theranostics; 2020; 10(9):3849-3866. PubMed ID: 32226524
[TBL] [Abstract][Full Text] [Related]
15. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
16. Application of exosome engineering modification in targeted delivery of therapeutic drugs.
Wang Y; Jiang M; Zheng X; He Y; Ma X; Li J; Pu K
Biochem Pharmacol; 2023 Sep; 215():115691. PubMed ID: 37481135
[TBL] [Abstract][Full Text] [Related]
17. New advances in exosome-based targeted drug delivery systems.
Ferreira D; Moreira JN; Rodrigues LR
Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next.
Song Y; Kim Y; Ha S; Sheller-Miller S; Yoo J; Choi C; Park CH
Am J Reprod Immunol; 2021 Feb; 85(2):e13329. PubMed ID: 32846024
[TBL] [Abstract][Full Text] [Related]
19. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.
Shao J; Zaro J; Shen Y
Int J Nanomedicine; 2020; 15():9355-9371. PubMed ID: 33262592
[TBL] [Abstract][Full Text] [Related]
20. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers.
Lakhal S; Wood MJ
Bioessays; 2011 Oct; 33(10):737-41. PubMed ID: 21932222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
